KTCC:NASDAQKey Tronic Corporation Analysis
Data as of 2026-05-19 - not real-time
$3.13
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Key Tronic (KTCC) trades around $3.13, sitting just above its 20‑day SMA (3.04) and comfortably above the 50‑day SMA (2.86), indicating short‑term price support. The RSI at 55.8 suggests the stock is neither overbought nor oversold, while a bullish MACD crossover (line 0.102 > signal 0.097) adds a modest technical upside. Volatility is high at 47.5% over the past 30 days, and beta of 0.66 points to lower systematic risk, yet the thin trading volume (≈3,600 shares today versus a 10‑day average of 18,560) raises liquidity concerns. On the fundamentals side, revenue has slipped 20% year‑over‑year, margins are deeply negative, and the company carries a debt‑to‑equity ratio above 120%, but cash flow has shown improvement and management is targeting a return to profitability. Recent news notes that the shares rallied >10% after a Q3 loss, driven by optimism around cash‑flow recovery and a turnaround plan. Overall, the stock appears priced well below book (P/B 0.32) and has a low price‑to‑sales multiple (0.09), but the earnings outlook remains weak.
Given the blend of technical support, extreme market greed (Fear‑Greed Index 89.6), and a precarious balance sheet, KTCC presents a speculative upside play contingent on the company’s ability to reverse its loss trend. Investors should weigh the attractive valuation against the high volatility, liquidity constraints, and substantial debt load before committing.
Given the blend of technical support, extreme market greed (Fear‑Greed Index 89.6), and a precarious balance sheet, KTCC presents a speculative upside play contingent on the company’s ability to reverse its loss trend. Investors should weigh the attractive valuation against the high volatility, liquidity constraints, and substantial debt load before committing.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Technical support from SMA crossover and bullish MACD
- Recent share price rally on improving cash flow
- Low valuation relative to book and sales
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued earnings losses and high debt load
- Uncertain timing of profitability turnaround
- Elevated volatility and liquidity constraints
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Sustained negative margins and cash flow uncertainty
- Potential sector headwinds for EMS providers
- Risk of financial distress given high debt‑to‑equity
Key Metrics & Analysis
Financial Health
Revenue Growth-20.00%
Profit Margin-4.40%
ROE-15.60%
ROA-2.69%
Debt/Equity122.18
P/B Ratio0.3
Industry P/E38.2
Technical Analysis
TrendNeutral
RSI55.8
Support$2.79
Resistance$3.45
MA 20$3.04
MA 50$2.86
MA 200$2.94
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.66
Volatility47.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.